Core Insights - The 24th Annual Orthopedic Conference and the 17th COA Academic Conference opened in Tianjin, with Liansheng Pharmaceutical Group showcasing its core transdermal drug delivery system (TDDS) products, including the Musk Blood Activating and Stasis Resolving Ointment and Ketoprofen Patch, which became a highlight of the event [1] Group 1: Conference Highlights - The conference theme was "Digital Intelligence in Orthopedics: Exploring New Frontiers," emphasizing the use of digital tools to empower orthopedic development [1] - Professor Wang Kunzheng, Chairman of the 12th Committee of the Orthopedic Branch of the Chinese Medical Association, highlighted the significance of the conference coinciding with the 45th anniversary of the Orthopedic Branch and the 20th anniversary of the COA conference [1] Group 2: Company Positioning - Liansheng Pharmaceutical Group, a leader in transdermal drug delivery in the bone health sector for over 20 years, prioritizes patient interests and is committed to providing safe and effective treatment solutions [1] - The company aims to uphold its mission of "making life healthier and more joyful" through high-quality products and technological innovation to safeguard public musculoskeletal health [1]